Literature DB >> 9217974

Clinical aspects of CAG repeat diseases.

M A Nance1.   

Abstract

Seven neurodegenerative disorders are known to be caused by unstable expansions of the trinucleotide CAG within human genes, and more will be discovered in the coming years. These disorders share some clinical similarities, as well as some differences, which are summarized here. These diseases have unusual clinical genetic properties related to the dynamic nature of CAG repeat expansions, including instability of the repeat expansion in meiosis, particularly male meiosis; a strong correlation between onset age and size of the repeat expansion; anticipation (earlier disease onset in succeeding generations); new mutations arising from unstable, mutable alleles with a high-normal CAG repeat number; and reduced penetrance for alleles in the low-affected range. Much more remains to be learned about the molecular biology and clinical pathophysiology of this new class of genetic diseases.

Entities:  

Mesh:

Year:  1997        PMID: 9217974     DOI: 10.1111/j.1750-3639.1997.tb00892.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  17 in total

Review 1.  Polyglutamine pathogenesis.

Authors:  C A Ross; J D Wood; G Schilling; M F Peters; F C Nucifora; J K Cooper; A H Sharp; R L Margolis; D R Borchelt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Huntington's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

Review 3.  Antioxidants in Huntington's disease.

Authors:  Ashu Johri; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2011-11-23

4.  Effects of mutant huntingtin on mGluR5-mediated dual signaling pathways: implications for therapeutic interventions.

Authors:  Shan-Shan Huang; Jun He; Dong-Ming Zhao; Xiao-Yuan Xu; Hui-Ping Tan; He Li
Journal:  Cell Mol Neurobiol       Date:  2010-07-20       Impact factor: 5.046

5.  Role of glutamine deamidation in neurodegenerative diseases associated with triplet repeat expansions: a hypothesis.

Authors:  Qurratulain Hasan; Ravindra Varma Alluri; Pragna Rao; Yog Raj Ahuja
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

6.  Glutamine and Asparagine Side Chain Hyperconjugation-Induced Structurally Sensitive Vibrations.

Authors:  David Punihaole; Zhenmin Hong; Ryan S Jakubek; Elizabeth M Dahlburg; Steven Geib; Sanford A Asher
Journal:  J Phys Chem B       Date:  2015-09-30       Impact factor: 2.991

Review 7.  PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond.

Authors:  Taiji Tsunemi; Albert R La Spada
Journal:  Prog Neurobiol       Date:  2011-11-09       Impact factor: 11.685

Review 8.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

9.  Generation of neuronal intranuclear inclusions by polyglutamine-GFP: analysis of inclusion clearance and toxicity as a function of polyglutamine length.

Authors:  K L Moulder; O Onodera; J R Burke; W J Strittmatter; E M Johnson
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

Review 10.  Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission.

Authors:  Ann Massie; Séverine Boillée; Sandra Hewett; Lori Knackstedt; Jan Lewerenz
Journal:  J Neurochem       Date:  2015-09-29       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.